Showing results (1-10 of 180) with videos related to
Sort By:
Pageof 18
Cytokine & Growth Factor Reviews|May 21, 2008
microRNAs and death receptorsSun-Mi Park, Marcus E PeterCurrent Opinion in Cell Biology|October 18, 2005
Nonapoptotic functions of FADD-binding death receptors and their signaling moleculesSun-Mi Park, Robert Schickel, Marcus E PeterInflammatory Bowel Diseases|January 6, 2010
Cell death in the colonic epithelium during inflammatory bowel diseases: CD95/Fas and beyondLina Chen, Sun-Mi Park, Jerrold R Turner, et al.Molecular Cell|July 13, 2010
miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1Robert Schickel, Sun-Mi Park, Andrea E Murmann, et al.Genes & Development|April 3, 2008
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2Sun-Mi Park, Arti B Gaur, Ernst Lengyel, et al.Endocrine-Related Cancer|September 26, 2009
The role of let-7 in cell differentiation and cancerBenjamin Boyerinas, Sun-Mi Park, Annika Hau, et al.Inflammatory Bowel Diseases|January 6, 2010
CD95 is cytoprotective for intestinal epithelial cells in colitisSun-Mi Park, Lina Chen, Manling Zhang, et al.Apoptosis : an International Journal on Programmed Cell Death|October 24, 2007
CD95 signaling deficient mice with a wild-type hematopoietic system are prone to hepatic neoplasiaSun-Mi Park, Tharinda W Rajapaksha, Manling Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2011
Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasisMarion Zillhardt, Sun-Mi Park, Iris L Romero, et al.Cell Cycle (Georgetown, Tex.)|October 25, 2007
Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2Sun-Mi Park, Scott Shell, Amir Reza Radjabi, et al.Pageof 18